# ROSA® Hip System THA PMCF

> **NCT05497206** · NA · TERMINATED · sponsor: **Zimmer Biomet** · enrollment: 12 (actual)

## Conditions studied

- Osteoarthritis, Hip
- Avascular Necrosis of Hip

## Interventions

- **DEVICE:** One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System

## Key facts

- **NCT ID:** NCT05497206
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-06-05
- **Primary completion:** 2024-12-12
- **Final completion:** 2024-12-20
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** The data needed for regulatory submissions based on the current pace of the study, will not be available in the foreseeable future.
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05497206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05497206, "ROSA® Hip System THA PMCF". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05497206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*